Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Altium Capital Management

Latest statistics and disclosures from Altium Capital Management's latest quarterly 13F-HR filing:

Top 5 stock holdings are VERA, ADMA, XENE, ITCI, SRPT, and represent 33.83% of Altium Capital Management's stock portfolio.
Added to shares of these 10 stocks: SRPT (+$13M), SKYE (+$11M), ARGX (+$9.9M), AVDL (+$8.6M), CTNM (+$7.6M), RZLT (+$7.3M), ITCI (+$5.5M), MLTX (+$5.1M), INSM, ZVRA.
Started 20 new stock positions in CNTX, ALUR, CATX, RZLT, SKYE, APDN, CETX, AVDL, CTNM, VSEEW. INBS, MLTX, OTLK, ARGX, LXRX, SRPT, ANVS, APRE, RAPT, RARE.
Reduced shares in these 10 stocks: Viking Therapeutics Inc put (-$14M), Advisorshares Tr call (-$11M), Flamel Technologies Sa (-$9.3M), BHVN (-$7.7M), AXSM (-$7.1M), OLMA (-$6.8M), MIRM (-$5.2M), NGNE (-$5.1M), PRAX, LBPH.
Sold out of its positions in Advisorshares Tr call, Alpine Immune Sciences, AQST, ATXS, Flamel Technologies Sa, AZTR, BRSWF, DHACW, Gri Bio, Geron Corp Cmn Stock cmn.
Altium Capital Management was a net buyer of stock by $1.5M.
Altium Capital Management has $245M in assets under management (AUM), dropping by -2.99%.
Central Index Key (CIK): 0001746382

Tip: Access up to 7 years of quarterly data

Positions held by Altium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Altium Capital Management

Altium Capital Management holds 66 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Vera Therapeutics Cl A (VERA)	10.5	$26M		714k	36.18	View chart
Adma Biologics (ADMA)	6.9	$17M		1.5M	11.18	View chart
Xenon Pharmaceuticals (XENE)	5.7	$14M	+3%	361k	38.99	View chart
Intra Cellular Therapies (ITCI)	5.4	$13M	+70%	193k	68.49	View chart
Sarepta Therapeutics (SRPT)	5.3	$13M	NEW	82k	158.00	View chart
Insmed Com Par $.01 (INSM)	5.2	$13M	+58%	190k	67.00	View chart
Alimera Sciences Com New	4.9	$12M	-15%	2.2M	5.56	View chart
Skye Bioscience Com New (SKYE)	4.4	$11M	NEW	1.4M	8.01	View chart
Argenx Se Sponsored Adr (ARGX)	4.0	$9.9M	NEW	23k	430.04	View chart
Soleno Therapeutics (SLNO)	3.5	$8.7M	+39%	213k	40.80	View chart
Avadel Pharmaceuticals Com Shs (AVDL)	3.5	$8.6M	NEW	610k	14.06	View chart
Catalyst Pharmaceutical Partners (CPRX)	3.2	$7.7M		500k	15.49	View chart
Contineum Therapeutics Cl A (CTNM)	3.1	$7.6M	NEW	429k	17.61	View chart
Rezolute Com New (RZLT)	3.0	$7.3M	NEW	1.7M	4.30	View chart
Ascendis Pharma A/s Sponsored Adr (ASND)	2.8	$6.8M	+100%	50k	136.38	View chart
Viking Therapeutics (VKTX)	2.6	$6.5M	+43%	122k	53.01	View chart
Larimar Therapeutics (LRMR)	2.6	$6.4M	+27%	889k	7.25	View chart
Savara (SVRA)	2.6	$6.4M	+19%	1.6M	4.03	View chart
Zevra Therapeutics Com New (ZVRA)	2.3	$5.7M	+240%	1.2M	4.90	View chart
Moonlake Immunotherapeutics Class A Ord (MLTX)	2.1	$5.1M	NEW	115k	43.97	View chart
Xtant Med Hldgs Com New (XTNT)	1.9	$4.7M	-3%	7.4M	0.63	View chart
Axsome Therapeutics (AXSM)	1.6	$4.0M	-63%	50k	80.50	View chart
Realreal (REAL)	1.6	$4.0M	+56%	1.3M	3.19	View chart
Cybin Ord (CYBN)	1.5	$3.8M		14M	0.27	View chart
Outlook Therapeutics (OTLK)	1.5	$3.7M	NEW	502k	7.38	View chart
Ultragenyx Pharmaceutical (RARE)	1.2	$2.9M	NEW	70k	41.10	View chart
Oric Pharmaceuticals (ORIC)	1.2	$2.9M		405k	7.07	View chart
Female Health (VERU)	0.8	$1.9M	+7%	2.3M	0.84	View chart
Perspective Therapeutics Com New (CATX)	0.8	$1.9M	NEW	192k	9.97	View chart
Milestone Pharmaceuticals (MIST)	0.5	$1.3M	-16%	1.0M	1.32	View chart
Achieve Life Sciences (ACHV)	0.4	$1.0M	-74%	216k	4.70	View chart
Allurion Technologies Com Shs (ALUR)	0.4	$968k	NEW	970k	1.00	View chart
Annovis Bio Put Option (ANVS)	0.4	$895k	NEW	155k	5.76	View chart
Biovie Cl A New (BIVI)	0.3	$794k	-34%	2.0M	0.40	View chart
Context Therapeutics (CNTX)	0.3	$722k	NEW	360k	2.00	View chart
Karyopharm Therapeutics (KPTI)	0.3	$642k		740k	0.87	View chart
Rapt Therapeutics Call Option (RAPT)	0.2	$610k	NEW	200k	3.05	View chart
Fat Brands *w Exp 07/16/202 (FATBW)	0.2	$569k		200k	2.85	View chart
Aprea Therapeutics Com New (APRE)	0.2	$558k	NEW	137k	4.07	View chart
Spruce Biosciences (SPRB)	0.2	$420k	-29%	811k	0.52	View chart
Evoke Pharma Com New (EVOK)	0.1	$366k	-4%	692k	0.53	View chart
Boundless Bio (BOLD)	0.1	$322k	-58%	83k	3.87	View chart
Lexicon Pharmaceuticals Com New (LXRX)	0.1	$205k	NEW	122k	1.68	View chart
Intelligent Bio Solutions In (INBS)	0.1	$161k	NEW	84k	1.92	View chart
Perfect Moment Com Shs (PMNT)	0.1	$135k	-31%	63k	2.15	View chart
Nexgel *w Exp 12/01/202 (NXGLW)	0.0	$98k		225k	0.44	View chart
Cemtrex Com New (CETX)	0.0	$75k	NEW	340k	0.22	View chart
Wearable Devices *w Exp 09/14/202 (WLDSW)	0.0	$70k		1.4M	0.05	View chart
Quoin Pharmaceuticals Sponsored Ads (QNRX)	0.0	$60k	+55%	103k	0.58	View chart
Onfolio Holdings *w Exp 01/02/202 (ONFOW)	0.0	$50k		200k	0.25	View chart
Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW)	0.0	$44k		732k	0.06	View chart
Nexalin Technology *w Exp 99/99/999 (NXLIW)	0.0	$36k		105k	0.34	View chart
Applied Dna Sciences Com New (APDN)	0.0	$35k	NEW	86k	0.41	View chart
Vsee Health *w Exp 99/99/999 (VSEEW)	0.0	$33k	NEW	150k	0.22	View chart
Mobix Labs *w Exp 99/99/999 (MOBXW)	0.0	$27k		150k	0.18	View chart
Nls Pharmaceutics *w Exp 02/02/202 (NLSPW)	0.0	$6.9k		200k	0.03	View chart
Cea Industries *w Exp 02/11/202 (CEADW)	0.0	$3.8k		250k	0.01	View chart
Western Acqstn Ventures Corp *w Exp 99/99/999 (WAVSW)	0.0	$3.7k		100k	0.04	View chart
Cingulate *w Exp 12/10/202 (CINGW)	0.0	$2.9k		270k	0.01	View chart
Bitcoin Depot *w Exp 06/30/202 (BTMWW)	0.0	$2.4k		50k	0.05	View chart
Jeffs Brands *w Exp 99/99/999 (JFBRW)	0.0	$2.2k		69k	0.03	View chart
Conduit Pharmaceuticals *w Exp 09/22/202 (CDTTW)	0.0	$1.6k		100k	0.02	View chart
Coliseum Acquisition Corp *w Exp 08/22/202 (MITAW)	0.0	$1.4k		28k	0.05	View chart
Surrozen *w Exp 08/01/203 (SRZNW)	0.0	$1.4k		82k	0.02	View chart
Selina Hospitality *w Exp 10/27/202 (SLNWF)	0.0	$1.1k		101k	0.01	View chart
Tc Biopharm Holdings *w Exp 02/10/202 (TCBPW)	0.0	$235.287500		19k	0.01	View chart

Past Filings by Altium Capital Management

SEC 13F filings are viewable for Altium Capital Management going back to 2020

Altium Capital Management 2024 Q2 filed Aug. 15, 2024
Altium Capital Management 2024 Q1 filed May 15, 2024
Altium Capital Management 2023 Q3 filed Nov. 14, 2023
Altium Capital Management 2023 Q2 filed Aug. 14, 2023
Altium Capital Management 2023 Q1 filed May 15, 2023
Altium Capital Management 2022 Q4 filed Feb. 14, 2023
Altium Capital Management 2022 Q3 filed Nov. 14, 2022
Altium Capital Management 2022 Q2 filed Aug. 15, 2022
Altium Capital Management 2022 Q1 filed May 16, 2022
Altium Capital Management 2021 Q4 filed Feb. 14, 2022
Altium Capital Management 2021 Q3 restated filed Nov. 17, 2021
Altium Capital Management 2021 Q3 filed Nov. 15, 2021
Altium Capital Management 2021 Q2 filed Aug. 13, 2021
Altium Capital Management 2021 Q1 filed May 6, 2021
Altium Capital Management 2020 Q4 restated filed May 5, 2021
Altium Capital Management 2020 Q4 filed Feb. 16, 2021

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z